S 2035 Massachusetts 194th session
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
By Mr. Lewis, a petition (accompanied by bill, Senate, No. 2035) of Jason M. Lewis and Rebecca L. Rausch for legislation to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Revenue.
Status
- Introduced
- Committee
- Floor vote
- Passed
- Enacted
In committee — last recorded action July 23, 2026
Accompanied a study order, see H5596
Passage likelihood
34% Comparable to other bills at this stage
This is an estimate, not a guarantee. It is computed from the signals listed below and nothing else. It does not account for leadership priorities, floor scheduling, or negotiations that are not in the public record.
What the estimate is based on
- Historical base rate About 20% of introduced state bills are enacted.
- Current stage Referred to committee.
- Cosponsors 1 cosponsor.
State-level impact
State-level impact data is not available for this bill. The source text does not contain a per-state funding formula or scored breakdown, so no figures are shown.
Official actions
- Accompanied a study order, see H5596
- Reporting date extended to Thursday June 25, 2026
- Hearing scheduled for 10/28/2025 from 01:00 PM-05:00 PM in B-2
- House concurred
- Referred to the committee on Revenue